Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 716
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07715903 Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metas… |
Carfilzomib | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-11-11 → 2031-12-31 | Ouvrir |
| NCT07582159 Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chro… |
Acalabrutinib | SEP | Phase 2 | RECRUITING | En attente / non publié | City of Hope Medical Center | United States · City of Hope at Irvine Lennar, Irvine… | 2026-12-19 → 2029-04-14 | Ouvrir |
| NCT05608044 A Study of Botensilimab and Balstilimab for the Treatment of Colorectal… |
Botensilimab | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Agenus Inc. | United States, Belgium, Brazil, France, Georgia, Ital… | 2022-11-30 → 2029-09 | Ouvrir |
| NCT06780085 A Study of Investigational Agents in Participants With Previously Treat… |
Raludotatug Deruxtecan | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Chile, Germany, Greece, Hungary, Israe… | 2025-05-13 → 2032-03-12 | Ouvrir |
| NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination Wi… |
Pembrolizumab | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Austria, Belgium, Brazil, C… | 2026-01-19 → 2031-10-29 | Ouvrir |
| NCT07731789 Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicul… |
Rituximab | SEP | Phase 2 | RECRUITING | En attente / non publié | Claudio Gobbi | United States · Fred Hutch/University of Washington C… | 2026-10-09 → 2032-10-29 | Ouvrir |
| NCT04206943 ISIKOK-19 — Study of CD19 Specific Chimeric Antigen Receptor Positive T… |
Car-T Cell Therapy | SEP | Phase 1/2 | UNKNOWN | En attente / non publié | Acibadem University | Turkey (Türkiye) · Acıbadem Labcell Cellular Therapy … | 2019-10-12 → 2021-01-01 | Ouvrir |
| NCT00695409 Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT Fo… |
Rituximab | SEP | Phase 2 | COMPLETED | En attente / non publié | Claudio Gobbi | United States · City of Hope Medical Center, Duarte, … | 2008-03-18 → 2017-03-27 | Ouvrir |
| NCT06922604 Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central… |
Biospecimen Collection | SEP | Phase 1 | SUSPENDED | En attente / non publié | Roswell Park Cancer Institute | United States · City of Hope Medical Center, Duarte, … | 2025-07-30 → 2029-01-02 | Ouvrir |
| NCT07659704 CLEVER-SLE — CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lu… |
Autologous CD19-Directed CAR-T Ce… | Lupus | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | University of Sao Paulo | Brazil · Hospital das Clínicas da Faculdade de Medici… | 2026-10-01 → 2028-10-01 | Ouvrir |
| NCT06223295 ENFORCE — Effectiveness of Focal Therapy in Men With Prostate Cancer |
Focal Therapy | Cancer | Non applicable | RECRUITING | En attente / non publié | Columbia University | Netherlands · Amsterdam UMC, Amsterdam, Netherlands |… | 2024-02-01 → 2031-02 | Ouvrir |
| NCT00030290 Ultrasound in Treating Patients With Prostate Cancer Confined to the Pr… |
high-intensity focused ultrasound… | Cancer | Phase 1 | COMPLETED | En attente / non publié | Focus Surgery | United States · Indiana University Cancer Center, Ind… | 2001-10 → 2006-02 | Ouvrir |
| NCT06590259 A Study on the Efficacy and Safety of Multi-mode Ablation Combined With… |
Multi-mode tumor treatment system | Cancer | Phase 2 | RECRUITING | En attente / non publié | Shanghai 6th People's Hospital | China · Shanghai Sixth People's Hospital, Shanghai, C… | 2024-03-12 → 2027-12 | Ouvrir |
| NCT01679470 Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Meta… |
AuroLase Therapy | Cancer | Non applicable | TERMINATED | En attente / non publié | Nanospectra Biosciences, Inc. | United States · Cancer Treatment Centers of America E… | 2012-10 → 2014-06 | Ouvrir |
| NCT04635137 Ablation and Cementoplasty for Painful Bone Lesions |
Ablation and Cementoplasty | Cancer | Non applicable | UNKNOWN | En attente / non publié | University of Calgary | Canada · Foothills Medical Centre, Calgary, Canada | … | 2021-06 → 2023-03 | Ouvrir |
| NCT03634579 MRI Guided Prostate Cancer Focal Laser Ablation |
MRI Guided Focal Laser Interstiti… | Cancer | Non applicable | TERMINATED | En attente / non publié | Emory University | United States · Emory University Hospital, Atlanta, U… | 2018-06-01 → 2019-03-15 | Ouvrir |
| NCT04002479 Alpha Radiation Emitters Device for the Treatment of Advanced Pancreati… |
Radiation: Diffusing Alpha Radiat… | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Alpha Tau Medical LTD. | Canada · Centre Hospitalier de l'Universite de Montre… | 2020-10-20 → 2026-10 | Ouvrir |
| NCT06739031 Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric F… |
PEF Treatment | Cancer | Non applicable | RECRUITING | En attente / non publié | Energenx Medical LTD. | China · Shanghai Chest Hospital, Shanghai Jiao Tong U… | 2024-12-25 → 2027-08-25 | Ouvrir |
| NCT04732520 INCITE ES — Feasibility Study of the Aliya System in the Treatment of E… |
Pulsed electric field treatment u… | Cancer | Non applicable | COMPLETED | En attente / non publié | Galvanize Therapeutics, Inc. | Hong Kong, Netherlands, Spain · Fundacion Instituto d… | 2021-03-31 → 2024-02-13 | Ouvrir |
| NCT02578667 Gorbly Compression Device for Use in Image-guided Procedures |
Gorbly Compression Device | Cancer | Non applicable | WITHDRAWN | En attente / non publié | University of Miami | United States · Jackson Memorial Hospital, Miami, Uni… | 2015-12 → 2016-01 | Ouvrir |
| NCT03845751 EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation The… |
HIFU hemi-ablation combined with … | Cancer | Phase 2 | COMPLETED | En attente / non publié | Institut Mutualiste Montsouris | France · Institut Mutualiste Montsouris, Paris, France | 2023-03-07 → 2026-07-06 | Ouvrir |
| NCT02680535 MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Direc… |
AuroShell particle infusion | Cancer | Non applicable | COMPLETED | En attente / non publié | Nanospectra Biosciences, Inc. | United States · Icahn School of Medicine at Mount Sin… | 2016-02 → 2020-10 | Ouvrir |
| NCT04305925 Focal Laser Ablation of Prostate Cancer |
Focal Laser Ablation | Cancer | Phase 1 | COMPLETED | En attente / non publié | Jonsson Comprehensive Cancer Cent… | United States · University of California at Los Angel… | 2020-01-30 → 2026-04-15 | Ouvrir |
| NCT07766187 CODAH — Combination Therapy Using Durvalumab and Histotripsy for Treatm… |
Histotripsie — HistoSonics Edison… | Cancer | Phase 2 | RECRUITING | En attente / non publié | Northwell Health | United States · University of Wisconsin, Madison, Uni… | 2026-11 → 2032-08 | Ouvrir |
| NCT03047135 Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer … |
olaparib | Cancer | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Sidney Kimmel Comprehensive Cance… | United States · Allegheny Cancer Center, Pittsburgh, … | 2017-03-01 → 2027-05-01 | Ouvrir |